SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Shepard Jay

(Last) (First) (Middle)
C/O ESPERION THERAPEUTICS, INC.
3891 RANCHERO DRIVE, SUITE 150

(Street)
ANN ARBOR MI 48108

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
05/24/2018
3. Issuer Name and Ticker or Trading Symbol
Esperion Therapeutics, Inc. [ ESPR ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
No securities are beneficially owned.
/s/ Richard B. Bartram, by power of attorney 05/29/2018
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
LIMITED POWER OF ATTORNEY


The undersigned hereby constitutes and appoints each of Tim M. 
Mayleben and Richard B. Bartram, signing singly, and with full 
power of substitution, the undersigned's true and lawful 
attorney-in-fact to:

(1)     execute for and on behalf of the undersigned, in the 
undersigned's capacity as an officer and/or director of Esperion 
Therapeutics, Inc. (the "Company"), from time to time the 
following U.S. Securities and Exchange Commission ("SEC") forms: 
(i) Form ID, including any attached documents, to effect the 
assignment of codes to the undersigned to be used in the 
transmission of information to the SEC using the EDGAR System; 
(ii) Form 3, Initial Statement of Beneficial Ownership of 
Securities, including any attached documents;  (iii) Form 4, 
Statement of Changes in Beneficial Ownership of Securities, 
including any attached documents; (iv) Form 5, Annual Statement 
of Beneficial Ownership of Securities in accordance with Section 
16(a) of the Securities Exchange Act of 1934, as amended, and the 
rules thereunder, including any attached documents; (v) Schedule 
13D and (vi) amendments of each thereof, in accordance with the 
Securities Exchange Act of 1934, as amended, and the rules 
thereunder, including any attached
 documents;

(2)     do and perform any and all acts for and on behalf of the 
undersigned which may be necessary or desirable to complete and 
execute any such Form 3, 4 or 5, Schedule 13D or any amendment(s) 
thereto, and timely file such form(s) with the SEC and any 
securities exchange, national association or similar authority; 
and

(3)     take any other action of any type whatsoever in 
connection with the foregoing which, in the opinion of such 
attorney-in-fact, may be of benefit to, in the best interest of, 
or legally required by, the undersigned, it being understood that 
the documents executed by such attorney-in-fact on behalf of the 
undersigned pursuant to this Power of Attorney shall be in such 
form and shall contain such terms and conditions as such 
attorney-in-fact may approve in such attorney-in-fact's 
discretion.

     The undersigned hereby grants to each such attorney-in-fact, 
acting singly, full power and authority to do and perform any and 
every act and thing whatsoever requisite, necessary or proper to 
be done in the exercise of any of the rights and powers herein 
granted, as fully to all intents and purposes as the undersigned 
might or could do if personally present, with full power of 
substitution or revocation, hereby ratifying and confirming all 
that such attorney-in-fact, or such attorney-in-fact's substitute 
or substitutes, shall lawfully do or cause to be done by virtue 
of this power of attorney and the rights and powers herein 
granted.  The undersigned acknowledges that the foregoing 
attorneys-in-fact, in serving in such capacity at the request of 
the undersigned, are not assuming, nor is the Company assuming, 
any of the undersigned's responsibilities to comply with Section 
16 or Regulation 13D-G of the Securities Exchange Act of 1934, as 
amended.  The undersigned hereby agrees to indemnify the attorney 
in fact and the Company from and against any demand, damage, 
loss, cost or expense arising from any false or misleading 
information provided by the undersigned to the attorney-in fact.

     This Power of Attorney shall remain in full force and effect 
until the undersigned is no longer required to file such forms 
with respect to the undersigned's holdings of and transactions in 
securities issued by the Company, unless earlier revoked by the 
undersigned in a signed writing delivered to the foregoing 
attorneys-in-fact.

     IN WITNESS WHEREOF, the undersigned has caused this Power of 
Attorney to be executed as of May 24, 2018.

/s/ Jay P. Shepard
________________
Jay P. Shepard